Grupo Español De Linfomas Y Transplante Autólogo De Médula Ósea

This study is testing a personalized cell therapy called axicabtagene ciloleucel (a type of CAR-T) in patients whose aggressive lymphoma has returned more than a year after their first treatment. It aims to see if this therapy can provide a strong and lasting response for this sp…

This international study is testing a new two-drug combination for adults newly diagnosed with a slow-growing form of mantle cell lymphoma. The goal is to see if the drugs pirtobrutinib and rituximab can effectively control the disease while being easier to tolerate than standard…